Stocktoria
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. 600436.SS
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (CN¥44.06); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. trades at about 37× earnings — below its 10-year norm (10-year range 41.1×–75.8×, median 44.8×).
Shaded band = 10-year range (41.1×–75.8×); dot = today's 37×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 36.4% | 42.7% | 46.8% | 45.6% |
| Operating margin | 25.0% | 31.9% | 32.4% | 32.9% |
| Net margin | 24.0% | 27.6% | 27.8% | 28.4% |
| FCF margin | -2.9% | 2.3% | 20.5% | 77.0% |
| Return on assets | 12.3% | 17.0% | 16.4% | 16.9% |
| Return on equity | 14.8% | 20.9% | 20.9% | 21.8% |
| Debt / equity | 0.00× | 0.00× | 0.00× | — |
| Current ratio | 5.02 | 4.77 | 5.24 | 5.06 |
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.